When calculating the estimated daily tumor growth via the formula: (Tumor volume on Day 25)/25, we found that NALM-6 xenograft growth in vivo was inhibited by HBO1 knockdown (Fig. 7B). The gene discussed is KAT7; the disease is neoplasm.